Results 1 - 9 of 9 in Angioedema
-
... the Cubist territory. Dyax retains exclusive rights to DX-88 in all other indications, including its hereditary angioedema program, currently in its second Phase 3 trial, as well as for the manufacturing of DX-88. Dyax also plans to develop DX-88 in ...
Comment?
-
Dyax Corp. and Cubist Pharmaceuticals, Inc. Sign Development and...
... the Cubist territory. Dyax retains exclusive rights to DX-88 in all other indications, including its hereditary angioedema program, currently in its second Phase 3 trial, as well as for the manufacturing of DX-88. Dyax also plans to develop DX-88 in ...
Comment?
-
... safety of prophylactic use of its C1 inhibitor (C1INH) replacement therapy, Cinryze , in patients with hereditary angioedema (HAE). The findings, presented at the annual meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI), ...
Comment?
-
Lev Presents Results of Phase III Study Supporting Safety and...
... of prophylactic use of its C1 inhibitor (C1INH) replacement therapy, Cinryze(TM), in patients with hereditary angioedema (HAE). The findings, presented at the annual meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI), ...
Comment?
-
Dyax Signs Sanofi to Antibody Deal Potentially Worth $500M
While it awaits results from a confirmatory trial with hereditary angioedema drug DX-88, Cambridge, Mass.-based Dyax Corp.
Comment?
-
FDA gives Jerini angioedema drug priority review
... have granted priority review of its Icatibant drug for the treatment of skin-swelling disease hereditary angioedema. Under the priority review process, which is given to products that address unmet medical needs, the agency has until April 26, 2008 ...
Comment?
-
Pharming Shares Sink On CHMP Rebuff For Rhucin
... Use (CHMP) adopted a negative opinion on a marketing authorization application for its lead drug, the hereditary angioedema treatment Rhucin. Pharming, of Leiden, the Netherlands, said it would apply later this month to seek a re-examination of the ...
Comment?
-
Novel Therapies May At Last Bring Relief For U.S. Hereditary Angioedema Patients
Although there is currently no treatment approved by the Federal Drug Administration for acute attacks of hereditary angioedema a genetic disease causing swelling of extremities, face and internal organs that ...
Comment?
-
Novel Therapies May At Last Bring Relief for U.S. Hereditary Angioedema Patients
Although there is currently no treatment approved by the Federal Drug Administration for acute attacks of hereditary angioedema - ' a genetic disease causing swelling of extremities, face and internal organs ...
Comment?
- « Previous
- 1
- Next »
Angioedema Forum
Most Popular
